DURECT is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol, DURECT’s lead drug candidate, binds to and inhibits the activity of DNA methyltransferases (DNMTs), epigenetic enzymes that are elevated and associated with hypermethylation found in alcohol-associated hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which FDA has granted a Fast Track Designation; non-alcoholic steatohepatitis (NASH) is also being explored. In addition, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER® platform technology, is FDA-approved and is exclusively licensed to Innocoll Pharmaceuticals for sale and distribution in the United States.
View Top Employees from DURECT CorporationWebsite | http://www.durect.com |
Ticker | DRRX |
Revenue | $18 million |
Funding | $208.9 million |
Employees | 110 (103 on RocketReach) |
Founded | 1998 |
Address | 10260 Bubb Rd, Cupertino, California 95014, US |
Phone | (408) 777-1417 |
Fax | (408) 777-3577 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Healthcare, Science and Engineering, Drug Delivery, Health Diagnostics, Health Care, Pharmaceutical |
Web Rank | 4 Million |
Keywords | Oradur Methylphenidate Er, Durect, Transdur®, Carboxy-Terminated 50 : 50 Plga Polymer (Lactel Absorbable Polymers, Birmingham, Al), Durect Corporation |
Competitors | Acrux, Heron Therapeutics, Inc., TARIS Bio, Titan Pharmaceuticals, Vanda Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular DURECT Corporation employee's phone or email?
The DURECT Corporation annual revenue was $18 million in 2024.
Dorothy Engelking is the Vice President Regulatory Affairs of DURECT Corporation.
103 people are employed at DURECT Corporation.
DURECT Corporation is based in Cupertino, California.
The NAICS codes for DURECT Corporation are [325, 32541, 32, 3254].
The SIC codes for DURECT Corporation are [283, 28].